Cover Image

Expansion of the phenotypic and genotypic spectrum for PRKAR1B-related Marbach-Schaaf neurodevelopmental syndrome: a case series

Show other versions (1)

Marbach-Schaaf neurodevelopmental syndrome (MASNS) is an ultra-rare, monogenic disease caused by pathogenic variation in PRKAR1B, which codes for the R1β regulatory subunit of protein kinase A (PKA), a key effector of cAMP signaling within the nervous system. This work provides a comprehensive clini...

Full description

Saved in:
Bibliographic Details
Main Authors: Burkart, Sebastian (Author) , Guzeloglu, Tarik (Author) , Soares, Ana R. (Author) , Valenzuela, Irene (Author) , Tizzano, Eduardo F. (Author) , Gómez-Andres, David (Author) , Pasquier, Laurent (Author) , Legendre, Marine (Author) , Berges, Camille (Author) , Thevenon, Julien (Author) , Gauthier, Marjolaine (Author) , Heid, Caleb (Author) , Ranum, Elly (Author) , Shen, Joseph (Author) , Frees, Michelle (Author) , Schmidtke, Michael W. (Author) , Caro, Pilar (Author) , Schaaf, Christian P. (Author)
Format: Article (Journal)
Language:English
Published: 29 October 2025
In: Clinical genetics
Year: 2025, Pages: 1-18
ISSN:1399-0004
DOI:10.1111/cge.70094
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/cge.70094
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/cge.70094
Get full text
Author Notes:Sebastian Burkart, Tarik Guzeloglu, Ana R. Soares, Irene Valenzuela, Eduardo F. Tizzano, David Gómez-Andres, Laurent Pasquier, Marine Legendre, Camille Berges, Julien Thevenon, Marjolaine Gauthier, Caleb Heid, Elly Ranum, Joseph Shen, Michelle Frees, Michael W. Schmidtke, Caro Pilar, Christian P. Schaaf
Description
Summary:Marbach-Schaaf neurodevelopmental syndrome (MASNS) is an ultra-rare, monogenic disease caused by pathogenic variation in PRKAR1B, which codes for the R1β regulatory subunit of protein kinase A (PKA), a key effector of cAMP signaling within the nervous system. This work provides a comprehensive clinical description of 12 subjects with pathogenic PRKAR1B variants, including two individuals with a heterozygous deletion including PRKAR1B, supporting haploinsufficiency as a possible mechanism of disease. Phenotypic information was obtained by interview, using a systematic multi-dimensional questionnaire. Besides expanding the evidence for established MASNS phenotypes like developmental delay, ID, ASD, pain insensitivity, as well as mild dysmorphisms, we broaden the clinical spectrum through the description of new and underreported findings, in particular increased body weight. In addition, the presence of genomic deletions suggests dosage sensitivity of PRKAR1B, demonstrating that both sequence and copy number variants should be considered in diagnostic testing. This work gives valuable insight into the pathophysiology of MASNS and sets a framework upon which to design future mechanistic studies of PKA signaling in brain development.
Item Description:Zuerst veröffentlicht: 29. Oktober 2025
Gesehen am 15.12.2025
Physical Description:Online Resource
ISSN:1399-0004
DOI:10.1111/cge.70094

Similar Items